Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29851 - 29875 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	RGS2	5997	upregulated	decitabine results in increased expression of RGS2 mRNA	1q31.2	A21919
Decitabine	Approved Investigational	RHOXF1	158800	upregulated	decitabine results in increased expression of RHOXF1 mRNA	Xq24	A22024
Decitabine	Approved Investigational	RHOXF2	84528	upregulated	decitabine results in increased expression of RHOXF2 mRNA	Xq24	A22024 A21915
Decitabine	Approved Investigational	RIN1	9610	upregulated	decitabine results in increased expression of RIN1 mRNA	11q13.2	A21978
Decitabine	Approved Investigational	RORA	6095	upregulated	decitabine results in increased expression of RORA mRNA	15q22.2	A21919
Decitabine	Approved Investigational	ROS1	6098	upregulated	decitabine results in increased expression of ROS1 mRNA	6q22.1	A22025
Decitabine	Approved Investigational	RPSA	3921	downregulated	decitabine results in decreased expression of RPSA mRNA	3p22.1	A21913
Decitabine	Approved Investigational	RRM2B	50484	upregulated	decitabine results in increased expression of RRM2B mRNA	8q22.3	A21009
Decitabine	Approved Investigational	RRP7A	27341	upregulated	decitabine results in increased expression of RRP7A mRNA	22q13.2	A21917
Decitabine	Approved Investigational	RSG1	79363	upregulated	decitabine results in increased expression of RSG1 mRNA	1p36.13	A20985
Decitabine	Approved Investigational	RTEL1	51750	downregulated	decitabine results in decreased expression of RTEL1 mRNA	20q13.33	A20985
Decitabine	Approved Investigational	RTN3	10313	downregulated	decitabine results in decreased expression of RTN3 mRNA	11q13	A21913
Decitabine	Approved Investigational	RUNX3	864	upregulated	decitabine results in increased expression of RUNX3 mRNA	1p36.11	A21919 A22026
Decitabine	Approved Investigational	RXRB	6257	upregulated	decitabine results in increased expression of RXRB mRNA	6p21.32	A21917
Decitabine	Approved Investigational	S100A10	6281	upregulated	decitabine results in increased expression of S100A10 mRNA	1q21.3	A21912
Decitabine	Approved Investigational	S100A2	6273	upregulated	decitabine results in increased expression of S100A2 mRNA	1q21.3	A21930
Decitabine	Approved Investigational	S100A3	6274	upregulated	decitabine results in increased expression of S100A3 mRNA	1q21.3	A21930
Decitabine	Approved Investigational	S100A4	6275	upregulated	decitabine results in increased expression of S100A4 mRNA	1q21.3	A20985
Decitabine	Approved Investigational	S100A5	6276	upregulated	decitabine results in increased expression of S100A5 mRNA	1q21.3	A21930
Decitabine	Approved Investigational	S100A6	6277	upregulated	decitabine results in increased expression of S100A6 mRNA	1q21.3	A20985
Decitabine	Approved Investigational	S100A9	6280	upregulated	decitabine results in increased expression of S100A9 mRNA	1q21.3	A20985
Decitabine	Approved Investigational	S100P	6286	upregulated	decitabine results in increased expression of S100P mRNA	4p16.1	A20985
Decitabine	Approved Investigational	SAMD5	389432	downregulated	decitabine results in decreased expression of SAMD5 mRNA	6q24.3	A21913
Decitabine	Approved Investigational	SASH3	54440	upregulated	decitabine results in increased expression of SASH3 mRNA	Xq26.1	A20985
Decitabine	Approved Investigational	SCAND1	51282	upregulated	decitabine results in increased expression of SCAND1 mRNA	20q11.23	A21917

Displaying entries 29851 - 29875 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability